Invesco-Ltd

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
14,357
Total Value
320244803394
Accession Number
0000914208-25-000230
Form Type
13F-HR
Manager Name
Invesco-Ltd
Data Enrichment
96% identified
13,831 identified526 unidentified

Holdings

14,357 positions • $320.2B total value
Manager:
Search and click to pin securities to the top
Page 182 of 188
Spire Global, Inc.
Shares:10.6K
Value:$85.4K
% of Portfolio:0.0% ($85.4K/$320.2B)
Cabaletta Bio, Inc.
Shares:61.7K
Value:$85.4K
% of Portfolio:0.0% ($85.4K/$320.2B)
Butterfly Network, Inc.
Shares:37.1K
Value:$84.5K
% of Portfolio:0.0% ($84.5K/$320.2B)
Melco Resorts & Entertainment LTD
Shares:16.0K
Value:$84.2K
% of Portfolio:0.0% ($84.2K/$320.2B)
DouYu International Holdings Ltd
Shares:11.2K
Value:$83.9K
% of Portfolio:0.0% ($83.9K/$320.2B)
PLIANT THERAPEUTICS, INC.
Shares:61.9K
Value:$83.6K
% of Portfolio:0.0% ($83.6K/$320.2B)
00770C101
Shares:19.5K
Value:$81.5K
% of Portfolio:0.0% ($81.5K/$320.2B)
Evolv Technologies Holdings, Inc.
Shares:26.1K
Value:$81.4K
% of Portfolio:0.0% ($81.4K/$320.2B)
STEM, INC.
Shares:221.8K
Value:$77.7K
% of Portfolio:0.0% ($77.7K/$320.2B)
scPharmaceuticals Inc.
Shares:28.7K
Value:$75.5K
% of Portfolio:0.0% ($75.5K/$320.2B)
ThredUp Inc.
Shares:30.0K
Value:$72.3K
% of Portfolio:0.0% ($72.3K/$320.2B)
Acrivon Therapeutics, Inc.
Shares:35.3K
Value:$71.7K
% of Portfolio:0.0% ($71.7K/$320.2B)
KALTURA INC
Shares:38.1K
Value:$71.7K
% of Portfolio:0.0% ($71.7K/$320.2B)
Black Diamond Therapeutics, Inc.
Shares:46.0K
Value:$71.3K
% of Portfolio:0.0% ($71.3K/$320.2B)
Compass Therapeutics, Inc.
Shares:37.2K
Value:$70.6K
% of Portfolio:0.0% ($70.6K/$320.2B)
NEXPOINT DIVERSIFIED REAL ESTATE TRUST
Shares:18.1K
Value:$69.4K
% of Portfolio:0.0% ($69.4K/$320.2B)
Nano-X Imaging Ltd.
Shares:13.9K
Value:$69.3K
% of Portfolio:0.0% ($69.3K/$320.2B)
LINKBANCORP, Inc.
Shares:10.1K
Value:$68.5K
% of Portfolio:0.0% ($68.5K/$320.2B)
Westrock Coffee Co
Shares:9.5K
Value:$68.4K
% of Portfolio:0.0% ($68.4K/$320.2B)
RAPT Therapeutics, Inc.
Shares:55.4K
Value:$67.6K
% of Portfolio:0.0% ($67.6K/$320.2B)